Get started
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITEDTIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITEDTIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

600329 chart


Full chart

600329 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪30.26 B‬ CNY
Dividend yield (indicated)
3.65%
Price to earnings Ratio (TTM)
29.22
Basic EPS (TTM)
1.21 CNY
Net income (FY)
‪986.71 M‬ CNY
Revenue (FY)
‪8.14 B‬ CNY
Shares float
‪313.94 M‬
Beta (1Y)
1.41

Employees


Employees (FY)
‪4.62 K‬
Change (1Y)
−294 −5.98%
Revenue / Employee (1Y)
‪248.32 K‬ CNY
Net income / Employee (1Y)
‪30.09 K‬ CNY

About TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED


Sector
Health Technology
CEO
Lei Wang
Headquarters
Tianjin
Website
en.pharm.com.cn
Founded
1981
ISIN
CNE000001808
FIGI
BBG000CWRRX0
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. engages in the wholesale, retail and manufacturing of Chinese herbal medicines, Chinese patent medicines, Chinese herbal decoction pieces, western medicine preparations and health care products. The company was founded on December 29, 1981 and is headquartered in Tianjin, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

600329 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 600329 is 35.05 CNY — it has decreased by −1.07% in the past 24 hours. Watch TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stocks are traded under the ticker 600329.
600329 stock has risen by 7.02% compared to the previous week, the month change is a −7.28% fall, over the last year TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED has showed a 14.58% increase.
We've gathered analysts' opinions on TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED future price: according to them, 600329 price has a max estimate of 32.72 CNY and a min estimate of 32.72 CNY. Watch 600329 chart and read a more detailed TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock forecast: see what analysts think of TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED and suggest that you do with its stocks.
600329 reached its all-time high on May 29, 2023 with the price of 56.26 CNY, and its all-time low was 1.60 CNY and was reached on Jul 18, 2005. View more price dynamics on 600329 chart.
See other stocks reaching their highest and lowest prices.
600329 stock is 2.91% volatile and has beta coefficient of 1.41. Track TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock price on the chart and check out the list of the most volatile stocks — is TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED there?
Today TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED has the market capitalization of ‪33.96 B‬, it has decreased by −1.60% over the last week.
Yes, you can track TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financials in yearly and quarterly reports right on TradingView.
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
600329 net income for the last quarter is ‪146.14 M‬ CNY, while the quarter before that showed ‪270.39 M‬ CNY of net income which accounts for −45.95% change. Track more TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED financial stats to get the full picture.
Yes, 600329 dividends are paid annually. The last dividend per share was 1.28 CNY. As of today, Dividend Yield (TTM)% is 3.65%. Tracking TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED dividends might help you take more informed decisions.
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED dividend yield was 3.80% in 2023, and payout ratio reached 99.74%. The year before the numbers were 3.85% and 99.93% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED on this list?
Like other stocks, 600329 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED stock shows the buy signal. See more of TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.